| Follicular lymphoma international prognostic index P Solal-Céligny, P Roy, P Colombat, J White, JO Armitage, R Arranz-Saez, ... Blood 104 (5), 1258-1265, 2004 | 2131 | 2004 |
| Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial G Salles, JF Seymour, F Offner, A López-Guillermo, D Belada, L Xerri, ... The Lancet 377 (9759), 42-51, 2011 | 1232 | 2011 |
| Screening older cancer patients: first evaluation of the G-8 geriatric screening tool CA Bellera, M Rainfray, S Mathoulin-Pélissier, C Mertens, F Delva, ... Annals of Oncology 23 (8), 2166-2172, 2012 | 927 | 2012 |
| Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project M Federico, M Bellei, L Marcheselli, S Luminari, A Lopez-Guillermo, ... Journal of Clinical Oncology 27 (27), 4555-4562, 2009 | 849 | 2009 |
| Phase III trial of consolidation therapy with yttrium-90–ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma F Morschhauser, J Radford, A Van Hoof, U Vitolo, P Soubeyran, H Tilly, ... Journal of Clinical Oncology 26 (32), 5156-5164, 2008 | 528 | 2008 |
| Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study P Soubeyran, C Bellera, J Goyard, D Heitz, H Curé, H Rousselot, ... PloS one 9 (12), e115060, 2014 | 527 | 2014 |
| EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update C Bokemeyer, MS Aapro, A Courdi, J Foubert, H Link, A Österborg, ... European Journal of Cancer 43 (2), 258-270, 2007 | 487 | 2007 |
| Predictors of early death risk in older patients treated with first-line chemotherapy for cancer P Soubeyran, M Fonck, C Blanc-Bisson, JF Blanc, J Ceccaldi, C Mertens, ... Journal of Clinical Oncology 30 (15), 1829-1834, 2012 | 483 | 2012 |
| EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer C Bokemeyer, MS Aapro, A Courdi, J Foubert, H Link, A Österborg, ... European Journal of Cancer 40 (15), 2201-2216, 2004 | 359 | 2004 |
| High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial D Rossille, M Gressier, D Damotte, D Maucort-Boulch, C Pangault, ... Leukemia 28 (12), 2367-2375, 2014 | 353 | 2014 |
| High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non–AIDS-related primary central nervous system lymphoma: European Organization for Research … PMP Poortmans, HC Kluin-Nelemans, H Haaxma-Reiche, M Van’t Veer, ... Journal of Clinical Oncology 21 (24), 4483-4488, 2003 | 340 | 2003 |
| Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research … K Hoang-Xuan, L Taillandier, O Chinot, P Soubeyran, U Bogdhan, ... Journal of Clinical Oncology 21 (14), 2726-2731, 2003 | 269 | 2003 |
| Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ... Clinical cancer research 18 (19), 5203-5211, 2012 | 260 | 2012 |
| Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events V Rondeau, S Mathoulin-Pelissier, H Jacqmin-Gadda, V Brouste, ... Biostatistics 8 (4), 708-721, 2007 | 242 | 2007 |
| Functional decline in older patients with cancer receiving first-line chemotherapy S Hoppe, M Rainfray, M Fonck, L Hoppenreys, JF Blanc, J Ceccaldi, ... Journal of Clinical Oncology 31 (31), 3877-3882, 2013 | 241 | 2013 |
| 90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow … F Morschhauser, J Radford, A Van Hoof, B Botto, AZS Rohatiner, G Salles, ... Journal of Clinical Oncology 31 (16), 1977-1983, 2013 | 235 | 2013 |
| EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer L Repetto, L Biganzoli, CH Koehne, AS Luebbe, P Soubeyran, ... European Journal of Cancer 39 (16), 2264-2272, 2003 | 225 | 2003 |
| Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase … C Houillier, L Taillandier, S Dureau, T Lamy, M Laadhari, O Chinot, ... Journal of Clinical Oncology 37 (10), 823-833, 2019 | 217 | 2019 |
| IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas N Gachard, M Parrens, I Soubeyran, B Petit, A Marfak, D Rizzo, M Devesa, ... Leukemia 27 (1), 183-189, 2013 | 217 | 2013 |
| Impact of [(18) F] fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a … J Dupuis, A Berriolo-Riedinger, A Julian, P Brice, C Tychyj-Pinel, H Tilly, ... J Clin Oncol 30 (35), 4317-4322, 2012 | 203 | 2012 |
